Preventing the misidentification of patients receiving blood transfusions has been targeted as an important factor in reducing adverse events. But ensuring that this happens need not cost the earth, as Barry Hill discovered when he examined one company’s low-cost solution to the problem.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.